Colossal Biosciences Stock

colossal.comHealthcareFounded: 2021Funding to Date: $228.04MM

Colossal Biosciences is a biotechnology company with the mission to bring back into existence past animal species currently extinct. The company employs teams of researchers to uncover methods of rebuilding DNA systems using CRISPR and genetic engineering to reawaken prehistoric life and biology.

Register for Details

For more details on financing and valuation for Colossal Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Colossal Biosciences.

Register Today

Colossal Biosciences investors also invested in these private companies

Team

Management Team

Adam Milne
Chief Operating Officer
Brian Beard, J.D.
Chief Legal Officer
Sam Singer, CFA
Chief Financial Officer
Sarah Grant
Chief of Staff
Peter Phillips
Chief Business Officer
Andrew Busey
Chief Product Officer

Board Members

Alexander Titus
Independent Advisor

Other companies like Colossal Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B
Sector
Last Round Est. Valuation
$409.37MM

News

Inside the National Black-Footed Ferret Conservation Center, in Carr, Colorado, Dr. Della Garelle, a veterinarian with the U.S. Fish and Wildlife Service, is leading the effort to bring one of America's most endangered species back from the brink of extinction.
A biotechnology startup that promises to resurrect woolly mammoths is now the first “de-extinction unicorn,” with a valuation said to be over a $1 billion before bringing back a single lost species.